AzTrials
AzTrials

SmilePeriosmile1NCT07372105

Validation of the French Version of the SERQoL Questionnaire

An observational study of Smile and Smile Esthetics, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This observational study aims to validate the French version of the Smile Esthetics-Related Quality of Life (SERQoL) questionnaire in adult patients recruited in two APH-HP dental departments. The study evaluates internal consistency, test-retest reliability, and construct validity of the questionnary. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Smile, Smile Esthetics
How many people
120 participants
Where
1 siteFrance
Study dates
Jan 2026to Jul 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients attending a first consultation in the dental department of Rothschild or Charles Foix hospitals (AP-HP). Participants must speak and understand French and have not opposed participation.

Who may be able to join

  • Age ≥ 18 years
  • Patients attending their first periodontal consultation at the oral medicine departments of Rothschild Hospital (AP-HP) or Charles Foix Hospital (AP-HP)
  • Patients who speak and understand French well enough to read and understand the study information sheet.
  • Patients who are informed and do not object to participating in the study

Who cannot join

  • Patients under guardianship or curatorship
  • Patients who are completely edentulous, whether the edentulism is compensated or not
  • Patients with multiple dental agenesis (more than 6 teeth), amelogenesis, or syndromic or non-syndromic dentinogenesis imperfecta
  • Patients with psychiatric illnesses that may impact body image, such as patients with anorexia-bulimia or body dysmorphic disorder.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bruno TAVERNIER, PU-PH contact

+33 (0)1 40 19 39 85

bruno.tavernier@aphp.fr

Suzanne DIMPRE, CCU-AAH contact

00 33 1 40 19 39 85

dr.dimpre@gmail.com

France1 site
  • Hôpital Rotschild

    Paris, 75012

    Suzanne DIMPRE, CCU-AAH, +33 (0)1 40 19 39 85, dr.dimpre@gmail.com

Other trials in France

About this study

Official title: Validation of the French Version of the Smile Esthetics-Related Quality of Life (SERQoL) Questionnaire

This observational study aims to validate the French version of the Smile Esthetics-Related Quality of Life (SERQoL) questionnaire in adult patients recruited in two APH-HP dental departments. The study evaluates internal consistency, test-retest reliability, and construct validity of the questionnary. A total of 120 patients will be recruited from dental departments at two AP-HP hospitals.

Read the detailed description

This psychometric validation study involves adult patients receiving their first consultation at AP-HP dental services. The SERQoL questionnaire will be completed twice (at baseline and after 15 days). Internal consistency (Cronbach's alpha), test-retest reliability (intraclass or Pearson correlation), and factor structure (confirmatory factor analysis) will be analyzed. No clinical intervention is involved, and participation will not alter standard care.

Keywords
smile esthetics, life quality, SERQoL, psychometric validation, patient-reported outcomes
Medical subject headings
Smiling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of the internal consistency by the Cronbach's alpha

    Measure of the questionnaire internal consistency by the Cronbach's alpha

    Measured: Day 15

  2. Measure of the test-retest reliability by the intraclass or Pearson correlation

    Measure of the questionnaire test-retest reliability by the intraclass or Pearson correlation

    Measured: Day 15

  3. Measure of the factor structure by the confirmatory factor analysis.

    Measure of the questionnaire factor structure by the confirmatory factor analysis

    Measured: Day 15

Secondary outcomes (3)
  1. Average score measure by gender

    Average questionnaire score measure by gender

    Measured: Day 0

  2. Average score measure by age

    Average questionnaire score measure by gender

    Measured: Day 0

  3. Average score measure according to periodontal health status

    Average questionnaire score measure according to periodontal health status

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2026
  2. Study startJan 2026 (estimated)
  3. Primary completionJul 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07372105
Sponsor's protocol ID
APHP251033
Acronym
Periosmile1
Status last verified
Jan 2026
First submitted
20 Jan 2026
Last updated
28 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Smile and Smile Esthetics, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bruno TAVERNIER, PU-PH (+33 (0)1 40 19 39 85, bruno.tavernier@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of the internal consistency by the Cronbach's alpha (time frame: Day 15). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in